Sign In
Buy CMBM
$0.401
+0 (+0%)
At Close: Jun 23, 2026
Wall Street Analysts Believe Cambium (CMBM) Could Rally 39%: Here's is How to Trade
02:55pm, Monday, 28'th Nov 2022 Zacks Investment Research
The consensus price target hints at a 39% upside potential for Cambium (CMBM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate re
Here's Why Cambium (CMBM) is a Promising Portfolio Pick
01:56pm, Monday, 28'th Nov 2022 Zacks Investment Research
With healthy fundamentals and upward estimate revisions, Cambium (CMBM) appears to be an enticing investment option at the moment.
Here's Why Cambium (CMBM) is a Promising Portfolio Pick
10:32am, Monday, 28'th Nov 2022
With healthy fundamentals and upward estimate revisions, Cambium (CMBM) appears to be an enticing investment option at the moment.
Cambium (CMBM) Moves to Buy: Rationale Behind the Upgrade
05:00pm, Wednesday, 23'rd Nov 2022 Zacks Investment Research
Cambium (CMBM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cambium (CMBM) Moves to Buy: Rationale Behind the Upgrade
01:33pm, Wednesday, 23'rd Nov 2022
Cambium (CMBM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
11:53am, Tuesday, 15'th Nov 2022 Benzinga
Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday.
Stifel cut Neoleukin Th
Can Cambium (CMBM) Climb 27% to Reach the Level Wall Street Analysts Expect?
02:55pm, Thursday, 10'th Nov 2022 Zacks Investment Research
The average of price targets set by Wall Street analysts indicates a potential upside of 26.8% in Cambium (CMBM). While the effectiveness of this highly sought-after metric is questionable, the positi
Why Cambium Networks Is A Strong Buy After The Q3 2022 Report
12:14am, Tuesday, 08'th Nov 2022
Cambium Networks rallied after posting quarterly results. Strong demand lifted revenue above previous guidance while product refresh will fuel growth through 2023.
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
08:07am, Monday, 07'th Nov 2022 Benzinga
Gainers
Peak Bio, Inc. (NASDAQ: PKBO) shares surged 105.8% to close at $7.82 on Friday. Peak Bio reported closing of up to $100 million common stock purchase transaction with White Lion Capital. Lade
Cambium Networks Corporation (CMBM) Q3 2022 Earnings Call Transcript
05:05pm, Saturday, 05'th Nov 2022
Cambium Networks Corporation (NASDAQ:CMBM ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Peter Schuman - Vice President of Investor and Industry Analyst Relations
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
04:54pm, Friday, 04'th Nov 2022 Benzinga
Gainers
Peak Bio, Inc. (NASDAQ: PKBO) jumped 115% to $8.17. Peak Bio reported closing of up to $100 million common stock purchase transaction with White Lion Capital. Ladenburg Thalmann initiated cov
Block, MasTec, Universal Display And Some Other Big Stocks Moving Higher On Friday
03:26pm, Friday, 04'th Nov 2022 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Friday. Here are some big stocks recording gains in today’s session.
Willdan Group, Inc. (NASDAQ: WLDN) surged 27.6% to
Cambium (CMBM) Beats Q3 Earnings Estimates on Top-Line Growth
12:03pm, Friday, 04'th Nov 2022
Record demand for Enterprise products and higher Point-to-Point revenues help Cambium (CMBM) to beat third-quarter 2022 earnings estimates.
T-Mobile (TMUS) Misses Q3 Earnings and Revenue Estimates
09:15pm, Thursday, 27'th Oct 2022 Zacks Investment Research
T-Mobile (TMUS) delivered earnings and revenue surprises of -24.53% and 2.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cambium (CMBM) Moves 6% Higher: Will This Strength Last?
07:34am, Tuesday, 25'th Oct 2022 Zacks Investment Research
Cambium (CMBM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
